SMS Pharmaceuticals Limited (SMSPHARMA.NS)
NSE · INR · Healthcare · Drug Manufacturers - General
₹442.80 (+5.97%) as of
Key statistics
- Market cap
- 41.47B
- P/E (TTM)
- 39.71
- EPS (TTM)
- 11.15
- Dividend yield
- 0.10%
- 52-week range
- 270.10 – 494.45
- Beta
- 0.28
- Revenue (TTM)
- 8.98B
- Profit margin
- 11.41%
- Volume
- 336.29k
About SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Hyderabad, India
- Employees
- 1,617
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.